• No results found

Discovery, Cloning, Expression, Purification, and Characterization of Phosphoglycolate Phosphatase from Staphylococcus aureus

N/A
N/A
Protected

Academic year: 2019

Share "Discovery, Cloning, Expression, Purification, and Characterization of Phosphoglycolate Phosphatase from Staphylococcus aureus"

Copied!
82
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Figure 1: Mechanisms for HAD superfamily members. The four reaction mechanisms above show how the members of the HAD superfamily utilize a catalytic aspartic acid for catalysis
Figure 2: General HAD structure. Shown is the general structure found in members of the HAD superfamily
Figure 3:  Schematic of HAD family active sites.  The schematic shows the location of the four conserved motifs and how each coordinates with either the divalent metal ion cofactor or substrate
Figure 4: Sequence alignment of pNppase family members. The amino acid sequences of phosphoglycolate phosphatase from S
+7

References

Related documents

Citation: da Silva VJ, Aguiar-Neto MB, Teixeira DJST, Santos CRM, de Sousa MPA, da Silva TM, Ramos LAR, Bragio Bonaldo A (2019) Harvestmen occurrence database (Arachnida, Opiliones)

 Number of architectural performance monitoring events supported in a logical processor..  Software can use CPUID to discover architectural performance monitoring

Adapted or abbreviated versions of Health Literacy Survey (HLS) questionnaire represent the most frequent assessment tools: European Health Literacy Survey

Given that coronary artery disease is the major cause of death in the Western world, we speculated that this protective Ser249Ser TLR-6 genotype would be overrep- resented in an

In this paper we share our experiences in conducting a population based study of chronic diseases in the occupied Palestinian territory and describe the challenges faced, some of

The results were sensitive to: the remission rates maintained in responders to 'usual care' and to 5 mg/kg infliximab, the rate of remission induced by adalimumab in non-responders to

cases clinically regarded as paralytic polio- myelitis but which, on the basis of epi- demiologic and etiologic studies, did not appear to be attributable to